Comparison of alteplase and heparin in maintaining the patency of paediatric central venous haemodialysis lines: a randomised controlled trial
Identifieur interne : 007639 ( Main/Exploration ); précédent : 007638; suivant : 007640Comparison of alteplase and heparin in maintaining the patency of paediatric central venous haemodialysis lines: a randomised controlled trial
Auteurs : Nicola S. Gittins [Royaume-Uni] ; Yan L. Hunter-Blair [Royaume-Uni] ; John N S. Matthews [Royaume-Uni] ; Malcolm G. Coulthard [Royaume-Uni]Source :
- Archives of Disease in Childhood [ 0003-9888 ] ; 2007-06.
English descriptors
Abstract
Objectives: To determine whether the tissue plasminogen activator, alteplase, is more effective than heparin in preventing blood clots developing in children’s haemodialysis central lines between dialysis sessions. Design: A prospective double-blind, within-patient multiperiod cross-over controlled trial of instilling a “lock” of either heparin 5000 U/ml or alteplase 1 mg/ml into the central lines of two children haemodialysed twice weekly, and seven dialysed thrice weekly, over 10 weeks. Setting: A UK paediatric nephrology unit. Main outcome measures: Weight of blood clot aspirated from the line at the start of the next dialysis session. Results: The odds of a clot forming was 2.4 times greater with heparin than alteplase (95% CI 1.4 to 4.0; p = 0.001), and when present they were 1.9 times heavier (31 vs 15 mg; 95% CI 1.5 to 2.4; p<0.0005). There was no effect of inter-dialytic interval. One child required an alteplase infusion to clear a blocked line following a heparin lock. We subsequently changed our routine locks from heparin to alteplase. Comparing the year before and after that change, the incidence of blocked lines requiring an alteplase or urokinase infusion fell from 2.7 to 1.2 per child (p<0.03), and the need for surgical replacements from 0.7 to nil (p<0.02). Conclusion: Alteplase is significantly more effective than heparin in preventing clot formation in central haemodialysis lines. This reduces morbidity and improves preservation of central venous access. It is more expensive, though relatively economic if packaged into syringes and stored frozen until needed, but reduces the costs of unblocking or replacing clotted lines.
Url:
DOI: 10.1136/adc.2006.100065
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001E32
- to stream Istex, to step Curation: 001E32
- to stream Istex, to step Checkpoint: 001485
- to stream Main, to step Merge: 007792
- to stream Main, to step Curation: 007639
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Comparison of alteplase and heparin in maintaining the patency of paediatric central venous haemodialysis lines: a randomised controlled trial</title><author><name sortKey="Gittins, Nicola S" sort="Gittins, Nicola S" uniqKey="Gittins N" first="Nicola S" last="Gittins">Nicola S. Gittins</name></author><author><name sortKey="Hunter Blair, Yan L" sort="Hunter Blair, Yan L" uniqKey="Hunter Blair Y" first="Yan L" last="Hunter-Blair">Yan L. Hunter-Blair</name></author><author><name sortKey="Matthews, John N S" sort="Matthews, John N S" uniqKey="Matthews J" first="John N S" last="Matthews">John N S. Matthews</name></author><author><name sortKey="Coulthard, Malcolm G" sort="Coulthard, Malcolm G" uniqKey="Coulthard M" first="Malcolm G" last="Coulthard">Malcolm G. Coulthard</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:42457E1826029214FCCDEB59DC173E3BC54F1D7B</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1136/adc.2006.100065</idno><idno type="url">https://api.istex.fr/document/42457E1826029214FCCDEB59DC173E3BC54F1D7B/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001E32</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001E32</idno><idno type="wicri:Area/Istex/Curation">001E32</idno><idno type="wicri:Area/Istex/Checkpoint">001485</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001485</idno><idno type="wicri:doubleKey">0003-9888:2007:Gittins N:comparison:of:alteplase</idno><idno type="wicri:Area/Main/Merge">007792</idno><idno type="wicri:Area/Main/Curation">007639</idno><idno type="wicri:Area/Main/Exploration">007639</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Comparison of alteplase and heparin in maintaining the patency of paediatric central venous haemodialysis lines: a randomised controlled trial</title><author><name sortKey="Gittins, Nicola S" sort="Gittins, Nicola S" uniqKey="Gittins N" first="Nicola S" last="Gittins">Nicola S. Gittins</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Royal Victoria Infirmary, Newcastle upon Tyne</wicri:regionArea><wicri:noRegion>Newcastle upon Tyne</wicri:noRegion></affiliation></author><author><name sortKey="Hunter Blair, Yan L" sort="Hunter Blair, Yan L" uniqKey="Hunter Blair Y" first="Yan L" last="Hunter-Blair">Yan L. Hunter-Blair</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Newcastle General Hospital, Newcastle upon Tyne</wicri:regionArea><wicri:noRegion>Newcastle upon Tyne</wicri:noRegion></affiliation></author><author><name sortKey="Matthews, John N S" sort="Matthews, John N S" uniqKey="Matthews J" first="John N S" last="Matthews">John N S. Matthews</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>University of Newcastle upon Tyne, Newcastle upon Tyne</wicri:regionArea><wicri:noRegion>Newcastle upon Tyne</wicri:noRegion></affiliation></author><author><name sortKey="Coulthard, Malcolm G" sort="Coulthard, Malcolm G" uniqKey="Coulthard M" first="Malcolm G" last="Coulthard">Malcolm G. Coulthard</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Royal Victoria Infirmary, Newcastle upon Tyne</wicri:regionArea><wicri:noRegion>Newcastle upon Tyne</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Archives of Disease in Childhood</title><title level="j" type="abbrev">Arch Dis Child</title><idno type="ISSN">0003-9888</idno><idno type="eISSN">1468-2044</idno><imprint><publisher>BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</publisher><date type="published" when="2007-06">2007-06</date><biblScope unit="volume">92</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="499">499</biblScope></imprint><idno type="ISSN">0003-9888</idno></series><idno type="istex">42457E1826029214FCCDEB59DC173E3BC54F1D7B</idno><idno type="DOI">10.1136/adc.2006.100065</idno><idno type="href">archdischild-92-499.pdf</idno><idno type="PMID">17068072</idno><idno type="local">0920499</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0003-9888</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>alteplase</term><term>central venous line</term><term>heparin</term><term>thrombosis</term><term>tissue plasminogen activator</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Objectives: To determine whether the tissue plasminogen activator, alteplase, is more effective than heparin in preventing blood clots developing in children’s haemodialysis central lines between dialysis sessions. Design: A prospective double-blind, within-patient multiperiod cross-over controlled trial of instilling a “lock” of either heparin 5000 U/ml or alteplase 1 mg/ml into the central lines of two children haemodialysed twice weekly, and seven dialysed thrice weekly, over 10 weeks. Setting: A UK paediatric nephrology unit. Main outcome measures: Weight of blood clot aspirated from the line at the start of the next dialysis session. Results: The odds of a clot forming was 2.4 times greater with heparin than alteplase (95% CI 1.4 to 4.0; p = 0.001), and when present they were 1.9 times heavier (31 vs 15 mg; 95% CI 1.5 to 2.4; p<0.0005). There was no effect of inter-dialytic interval. One child required an alteplase infusion to clear a blocked line following a heparin lock. We subsequently changed our routine locks from heparin to alteplase. Comparing the year before and after that change, the incidence of blocked lines requiring an alteplase or urokinase infusion fell from 2.7 to 1.2 per child (p<0.03), and the need for surgical replacements from 0.7 to nil (p<0.02). Conclusion: Alteplase is significantly more effective than heparin in preventing clot formation in central haemodialysis lines. This reduces morbidity and improves preservation of central venous access. It is more expensive, though relatively economic if packaged into syringes and stored frozen until needed, but reduces the costs of unblocking or replacing clotted lines.</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country></list><tree><country name="Royaume-Uni"><noRegion><name sortKey="Gittins, Nicola S" sort="Gittins, Nicola S" uniqKey="Gittins N" first="Nicola S" last="Gittins">Nicola S. Gittins</name></noRegion><name sortKey="Coulthard, Malcolm G" sort="Coulthard, Malcolm G" uniqKey="Coulthard M" first="Malcolm G" last="Coulthard">Malcolm G. Coulthard</name><name sortKey="Hunter Blair, Yan L" sort="Hunter Blair, Yan L" uniqKey="Hunter Blair Y" first="Yan L" last="Hunter-Blair">Yan L. Hunter-Blair</name><name sortKey="Matthews, John N S" sort="Matthews, John N S" uniqKey="Matthews J" first="John N S" last="Matthews">John N S. Matthews</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007639 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 007639 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:42457E1826029214FCCDEB59DC173E3BC54F1D7B
|texte= Comparison of alteplase and heparin in maintaining the patency of paediatric central venous haemodialysis lines: a randomised controlled trial
}}
| This area was generated with Dilib version V0.6.31. |  |